drugset / Trial / NCT00020631
Pirfenidone in Treating Patients With Fibrosis Caused by Radiation Therapy for Cancer
Completed
National Cancer Institute (NCI)
Supportive care
Summary
RATIONALE: Pirfenidone may prevent or lessen fibrosis caused by radiation therapy. PURPOSE: Pilot trial to study the effectiveness of pirfenidone in preventing or lessening fibrosis in patients who have undergone radiation therapy for cancer.
Timeline
- Start
- 2001-10
- Primary completion
- —
- Completion
- 2007-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pirfenidone | Small molecule | — | Oral |